Multi-epitope T-cell Vaccine Shows Promise in Ovarian, Breast Cancer

TPIV200 stimulates T cells to attack ovarian and triple negative breast tumor cells that over-express the folate receptor alpha protein.

Source: CancerNetwork - May 16, 2018 Category: Cancer & Oncology Authors: By John Schieszer Tags: Breast Cancer Immuno Oncology News Ovarian Cancer Source Type: news